Douglas Ingram

Overview

Douglas Ingram received an average of $20M in total compensation, including $546K in salary, at Sarepta Therapeutics from 2017 to 2019.

Source: SEC filings on April 21, 2020, April 26, 2019, and April 26, 2018.

Related executives

We found 26 more executives who work or worked at Sarepta Therapeutics.

Gilmore MMSc

Sarepta Therapeutics

Chief Scientific Officer

Sandesh Mahatme

Sarepta Therapeutics

Chief Financial Officer

William Ciambrone

Sarepta Therapeutics

Executive Vice President, Technical Operations

David Howton

Sarepta Therapeutics

General Counsel

Alexander Cumbo

Sarepta Therapeutics

Executive Vice President, Chief Commercial Officer

Edward Kaye

Sarepta Therapeutics

Chief Executive Officer

Guriqbal Basi

Sarepta Therapeutics

Chief Scientific Officer

Catherine Stehman-Breen

Sarepta Therapeutics

Chief Medical Officer

News

You may also like